Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acinar Cell Cancer
Studies from C.M. Schmidt and co-researchers in the area of acinar cell cancer published
January 20th, 2009
According to a study from the United States, "Pancreatic acinar cell carcinoma (ACC) is a rare tumor with poorly defined prognosis. Our objective was to compare a large population of patients with ACC to pancreatic ductal cell adenocarcinoma (DCC) in order to determine distinguishing characteristics and to assess survival." "Patients were identified from the National Cancer Database. Regression methods were used to identify differences between ACC and DCC and to identify predictors of survival for resected ACC. Eight hundred sixty-five patients with ACC were identified. Median tumor size was 6.9 cm (vs. 4.6 cm DCC); 32.1% had nodal metastases (vs. 48.0% DCC); and 47%...
Source: Cancer Weekly (2009-01-20)
|
